FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
NVIDIA and Lilly Launch AI Co-Innovation Lab for Next-Generation Drug Discovery
NVIDIA and Lilly launch a $1 billion AI co-innovation lab in San…
The Emirates Drug Foundation approves gene therapy for gene replacement in a new age group of spinal muscular atrophy patients.
The Emirates Drug Authority (EDA) has announced the approval of Itvisma, a…
Event Highlights | API China 2025, Chongqing
Relive the moments from API China, where innovation, collaboration, and the future…
Abu Dhabi to host IFPI Forum 2025, uniting global experts on pharmaceutical inspection and quality assurance
The GMP community event comes along, and it is more than just…
GSK Partners with Hengrui Pharma to Advance COPD and Oncology Drug Pipeline
GSK plc announced it has entered into agreements with Hengrui Pharma to…
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
The 2025 Warren Alpert Foundation Prize has been awarded to three scientists…
Roche Announces Retirement of Key Executives
Roche announced that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche…
